img

Global Medicine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Medicine Market Research Report 2024

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
According to Mr Accuracy reports new survey, global Medicine market is projected to reach US$ 2075470 million in 2029, increasing from US$ 1475000 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Medicine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Mylan
Segment by Type
Brand Drugs
Generic Drug

Segment by Application


Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brand Drugs
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Medicine Market Perspective (2018-2029)
2.2 Medicine Growth Trends by Region
2.2.1 Global Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Medicine Historic Market Size by Region (2018-2024)
2.2.3 Medicine Forecasted Market Size by Region (2024-2029)
2.3 Medicine Market Dynamics
2.3.1 Medicine Industry Trends
2.3.2 Medicine Market Drivers
2.3.3 Medicine Market Challenges
2.3.4 Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medicine Players by Revenue
3.1.1 Global Top Medicine Players by Revenue (2018-2024)
3.1.2 Global Medicine Revenue Market Share by Players (2018-2024)
3.2 Global Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medicine Revenue
3.4 Global Medicine Market Concentration Ratio
3.4.1 Global Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medicine Revenue in 2022
3.5 Medicine Key Players Head office and Area Served
3.6 Key Players Medicine Product Solution and Service
3.7 Date of Enter into Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medicine Breakdown Data by Type
4.1 Global Medicine Historic Market Size by Type (2018-2024)
4.2 Global Medicine Forecasted Market Size by Type (2024-2029)
5 Medicine Breakdown Data by Application
5.1 Global Medicine Historic Market Size by Application (2018-2024)
5.2 Global Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Medicine Market Size (2018-2029)
6.2 North America Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Medicine Market Size by Country (2018-2024)
6.4 North America Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Medicine Market Size (2018-2029)
7.2 Europe Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Medicine Market Size by Country (2018-2024)
7.4 Europe Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medicine Market Size (2018-2029)
8.2 Asia-Pacific Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Medicine Market Size by Region (2018-2024)
8.4 Asia-Pacific Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Medicine Market Size (2018-2029)
9.2 Latin America Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Medicine Market Size by Country (2018-2024)
9.4 Latin America Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medicine Market Size (2018-2029)
10.2 Middle East & Africa Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Medicine Market Size by Country (2018-2024)
10.4 Middle East & Africa Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Medicine Introduction
11.1.4 Pfizer Revenue in Medicine Business (2018-2024)
11.1.5 Pfizer Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Medicine Introduction
11.2.4 Roche Revenue in Medicine Business (2018-2024)
11.2.5 Roche Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Medicine Introduction
11.3.4 Sanofi Revenue in Medicine Business (2018-2024)
11.3.5 Sanofi Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Medicine Introduction
11.4.4 Johnson & Johnson Revenue in Medicine Business (2018-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Detail
11.5.2 Merck & Co. (MSD) Business Overview
11.5.3 Merck & Co. (MSD) Medicine Introduction
11.5.4 Merck & Co. (MSD) Revenue in Medicine Business (2018-2024)
11.5.5 Merck & Co. (MSD) Recent Development
11.6 Novartis
11.6.1 Novartis Company Detail
11.6.2 Novartis Business Overview
11.6.3 Novartis Medicine Introduction
11.6.4 Novartis Revenue in Medicine Business (2018-2024)
11.6.5 Novartis Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Detail
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Medicine Introduction
11.7.4 AbbVie Revenue in Medicine Business (2018-2024)
11.7.5 AbbVie Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Medicine Introduction
11.8.4 Gilead Sciences Revenue in Medicine Business (2018-2024)
11.8.5 Gilead Sciences Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Detail
11.9.2 GlaxoSmithKline (GSK) Business Overview
11.9.3 GlaxoSmithKline (GSK) Medicine Introduction
11.9.4 GlaxoSmithKline (GSK) Revenue in Medicine Business (2018-2024)
11.9.5 GlaxoSmithKline (GSK) Recent Development
11.10 Amgen
11.10.1 Amgen Company Detail
11.10.2 Amgen Business Overview
11.10.3 Amgen Medicine Introduction
11.10.4 Amgen Revenue in Medicine Business (2018-2024)
11.10.5 Amgen Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Medicine Introduction
11.11.4 AstraZeneca Revenue in Medicine Business (2018-2024)
11.11.5 AstraZeneca Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Medicine Introduction
11.12.4 Bristol-Myers Squibb Revenue in Medicine Business (2018-2024)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 Eli Lilly
11.13.1 Eli Lilly Company Detail
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Medicine Introduction
11.13.4 Eli Lilly Revenue in Medicine Business (2018-2024)
11.13.5 Eli Lilly Recent Development
11.14 Teva
11.14.1 Teva Company Detail
11.14.2 Teva Business Overview
11.14.3 Teva Medicine Introduction
11.14.4 Teva Revenue in Medicine Business (2018-2024)
11.14.5 Teva Recent Development
11.15 Bayer
11.15.1 Bayer Company Detail
11.15.2 Bayer Business Overview
11.15.3 Bayer Medicine Introduction
11.15.4 Bayer Revenue in Medicine Business (2018-2024)
11.15.5 Bayer Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Medicine Introduction
11.16.4 Novo Nordisk Revenue in Medicine Business (2018-2024)
11.16.5 Novo Nordisk Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Detail
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Medicine Introduction
11.17.4 AbbVie Revenue in Medicine Business (2018-2024)
11.17.5 AbbVie Recent Development
11.18 Takeda
11.18.1 Takeda Company Detail
11.18.2 Takeda Business Overview
11.18.3 Takeda Medicine Introduction
11.18.4 Takeda Revenue in Medicine Business (2018-2024)
11.18.5 Takeda Recent Development
11.19 Boehringer Ingelheim
11.19.1 Boehringer Ingelheim Company Detail
11.19.2 Boehringer Ingelheim Business Overview
11.19.3 Boehringer Ingelheim Medicine Introduction
11.19.4 Boehringer Ingelheim Revenue in Medicine Business (2018-2024)
11.19.5 Boehringer Ingelheim Recent Development
11.20 Mylan
11.20.1 Mylan Company Detail
11.20.2 Mylan Business Overview
11.20.3 Mylan Medicine Introduction
11.20.4 Mylan Revenue in Medicine Business (2018-2024)
11.20.5 Mylan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Brand Drugs
Table 3. Key Players of Generic Drug
Table 4. Global Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Medicine Market Share by Region (2018-2024)
Table 8. Global Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Medicine Market Share by Region (2024-2029)
Table 10. Medicine Market Trends
Table 11. Medicine Market Drivers
Table 12. Medicine Market Challenges
Table 13. Medicine Market Restraints
Table 14. Global Medicine Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Medicine Market Share by Players (2018-2024)
Table 16. Global Top Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine as of 2022)
Table 17. Ranking of Global Top Medicine Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Medicine Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Medicine Product Solution and Service
Table 21. Date of Enter into Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Medicine Revenue Market Share by Type (2018-2024)
Table 25. Global Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Medicine Revenue Market Share by Type (2024-2029)
Table 27. Global Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Medicine Revenue Market Share by Application (2018-2024)
Table 29. Global Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Medicine Revenue Market Share by Application (2024-2029)
Table 31. North America Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Medicine Product
Table 49. Pfizer Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche Medicine Product
Table 54. Roche Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. Sanofi Company Detail
Table 57. Sanofi Business Overview
Table 58. Sanofi Medicine Product
Table 59. Sanofi Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 60. Sanofi Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Medicine Product
Table 64. Johnson & Johnson Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Merck & Co. (MSD) Company Detail
Table 67. Merck & Co. (MSD) Business Overview
Table 68. Merck & Co. (MSD) Medicine Product
Table 69. Merck & Co. (MSD) Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 70. Merck & Co. (MSD) Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Medicine Product
Table 74. Novartis Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. AbbVie Company Detail
Table 77. AbbVie Business Overview
Table 78. AbbVie Medicine Product
Table 79. AbbVie Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 80. AbbVie Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Medicine Product
Table 84. Gilead Sciences Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. GlaxoSmithKline (GSK) Company Detail
Table 87. GlaxoSmithKline (GSK) Business Overview
Table 88. GlaxoSmithKline (GSK) Medicine Product
Table 89. GlaxoSmithKline (GSK) Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 90. GlaxoSmithKline (GSK) Recent Development
Table 91. Amgen Company Detail
Table 92. Amgen Business Overview
Table 93. Amgen Medicine Product
Table 94. Amgen Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 95. Amgen Recent Development
Table 96. AstraZeneca Company Detail
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Medicine Product
Table 99. AstraZeneca Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Bristol-Myers Squibb Company Detail
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Medicine Product
Table 104. Bristol-Myers Squibb Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Eli Lilly Company Detail
Table 107. Eli Lilly Business Overview
Table 108. Eli Lilly Medicine Product
Table 109. Eli Lilly Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 110. Eli Lilly Recent Development
Table 111. Teva Company Detail
Table 112. Teva Business Overview
Table 113. Teva Medicine Product
Table 114. Teva Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 115. Teva Recent Development
Table 116. Bayer Company Detail
Table 117. Bayer Business Overview
Table 118. Bayer Medicine Product
Table 119. Bayer Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 120. Bayer Recent Development
Table 121. Novo Nordisk Company Detail
Table 122. Novo Nordisk Business Overview
Table 123. Novo Nordisk Medicine Product
Table 124. Novo Nordisk Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 125. Novo Nordisk Recent Development
Table 126. AbbVie Company Detail
Table 127. AbbVie Business Overview
Table 128. AbbVie Medicine Product
Table 129. AbbVie Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 130. AbbVie Recent Development
Table 131. Takeda Company Detail
Table 132. Takeda Business Overview
Table 133. Takeda Medicine Product
Table 134. Takeda Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 135. Takeda Recent Development
Table 136. Boehringer Ingelheim Company Detail
Table 137. Boehringer Ingelheim Business Overview
Table 138. Boehringer Ingelheim Medicine Product
Table 139. Boehringer Ingelheim Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 140. Boehringer Ingelheim Recent Development
Table 141. Mylan Company Detail
Table 142. Mylan Business Overview
Table 143. Mylan Medicine Product
Table 144. Mylan Revenue in Medicine Business (2018-2024) & (US$ Million)
Table 145. Mylan Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Medicine Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Medicine Market Share by Type: 2022 VS 2029
Figure 3. Brand Drugs Features
Figure 4. Generic Drug Features
Figure 5. Global Medicine Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Medicine Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Medicine Report Years Considered
Figure 11. Global Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Medicine Market Share by Region: 2022 VS 2029
Figure 14. Global Medicine Market Share by Players in 2022
Figure 15. Global Top Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicine as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Medicine Revenue in 2022
Figure 17. North America Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Medicine Market Share by Country (2018-2029)
Figure 19. United States Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Medicine Market Share by Country (2018-2029)
Figure 23. Germany Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Medicine Market Share by Region (2018-2029)
Figure 31. China Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Medicine Market Share by Country (2018-2029)
Figure 39. Mexico Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Medicine Market Share by Country (2018-2029)
Figure 43. Turkey Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Pfizer Revenue Growth Rate in Medicine Business (2018-2024)
Figure 46. Roche Revenue Growth Rate in Medicine Business (2018-2024)
Figure 47. Sanofi Revenue Growth Rate in Medicine Business (2018-2024)
Figure 48. Johnson & Johnson Revenue Growth Rate in Medicine Business (2018-2024)
Figure 49. Merck & Co. (MSD) Revenue Growth Rate in Medicine Business (2018-2024)
Figure 50. Novartis Revenue Growth Rate in Medicine Business (2018-2024)
Figure 51. AbbVie Revenue Growth Rate in Medicine Business (2018-2024)
Figure 52. Gilead Sciences Revenue Growth Rate in Medicine Business (2018-2024)
Figure 53. GlaxoSmithKline (GSK) Revenue Growth Rate in Medicine Business (2018-2024)
Figure 54. Amgen Revenue Growth Rate in Medicine Business (2018-2024)
Figure 55. AstraZeneca Revenue Growth Rate in Medicine Business (2018-2024)
Figure 56. Bristol-Myers Squibb Revenue Growth Rate in Medicine Business (2018-2024)
Figure 57. Eli Lilly Revenue Growth Rate in Medicine Business (2018-2024)
Figure 58. Teva Revenue Growth Rate in Medicine Business (2018-2024)
Figure 59. Bayer Revenue Growth Rate in Medicine Business (2018-2024)
Figure 60. Novo Nordisk Revenue Growth Rate in Medicine Business (2018-2024)
Figure 61. AbbVie Revenue Growth Rate in Medicine Business (2018-2024)
Figure 62. Takeda Revenue Growth Rate in Medicine Business (2018-2024)
Figure 63. Boehringer Ingelheim Revenue Growth Rate in Medicine Business (2018-2024)
Figure 64. Mylan Revenue Growth Rate in Medicine Business (2018-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed